Lipoatrophy is the predominant presentation of HIV-associated lipodystrophy in Southern India [6]

Clinical Infectious Diseases

Volumn 38, Issue 11, 2004, Pages 1646-1647

  Saghayam, Suneeta ^a   Chaguturu, Sreekanth K ^b   Kumarasamy, N ^a,d   Solomon, Suniti ^a   Mayer, Kenneth H ^b   Wanke, Christine ^c  

^a YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

^b MIRIAM HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VHS Medical Centre India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

CLINICAL FEATURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LETTER; LIPOATROPHY; PRIORITY JOURNAL;

ADULT; FEMALE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INDIA; MALE;

EID: 2942595973     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/392516     Document Type: Letter

References (1)

1. Kumarasamy N, Solomon S, Peters E, et al. Antiretroviral drugs in the treatment of people living with human immunodeficiency virus: experience in a South Indian tertiary referral centre. J Assoc Physicians India 2000; 48:390-3.